bpc-157 fda status is approved RFK Jr pushes for approval of peptide The experts will take votes

Of the 12 patients who received only BPC 157, 91.6% reported significant improvement in knee pain, suggesting BPC 157 may help relieve multiple types of knee pain

Changes in both gross clinical exam and microscopic structure of cartilage in the affected joints indicates that AOD9604 is effective in treating the root cause of osteoarthritis and may work as both a treatment and preventative

Dosage: 40 to 60 mcg per day Frequency: Once daily Administration: Subcutaneous or intramuscular Timing: Morning fasted or post-workout Cycle length: 4 to 6 weeks Time off: Equal to or longer than time on This range represents the most common dosing in research protocols

I am excited to wake up every day and live because I enjoy everything so much more